1. Escherichia coli FimH adhesins act synergistically with PapGII adhesins for enhancing establishment and maintenance of kidney infection
- Author
-
Wei Hung Lin, Ming Cheng Wang, Jiunn Jong Wu, An Bang Wu, Ching Hao Teng, and Chin Chung Tseng
- Subjects
0301 basic medicine ,Microbiology (medical) ,fimH ,030106 microbiology ,Mutant ,Biology ,Kidney ,medicine.disease_cause ,Microbiology ,Mice ,03 medical and health sciences ,0302 clinical medicine ,Kidney infection ,Genotype ,Escherichia coli ,medicine ,Animals ,Immunology and Allergy ,030212 general & internal medicine ,Gene ,Escherichia coli Infections ,Urinary tract infection ,Adhesins, Escherichia coli ,Mice, Inbred BALB C ,Pyelonephritis ,General Immunology and Microbiology ,Inoculation ,General Medicine ,medicine.disease ,biology.organism_classification ,Adhesins ,QR1-502 ,Bacterial adhesin ,papGII ,Infectious Diseases ,Urinary Tract Infections ,Female ,Fimbriae Proteins ,Bacteria - Abstract
Background: FimH adhesin is proposed to enhance Escherichia coli kidney infection by acting with PapGII adhesin, but genetic epidemiology study and animal study have not been widely conducted to confirm this hypothesis. Methods: We compared the prevalence of adhesin gene and their coexistent pattern between upper and lower urinary tract infection (UTI) strains. fimH mutant (EC114FM), papGII mutant (EC114PM) and fimH/papGII double mutant (EC114DM) were constructed from a pylonephritogenic strain (EC114). We compared among these strains for the infection ability in bladders and kidneys of female BALB/c mice challenged transurethrally with these bacteria and assessed 1, 3, and 7 days after inoculation. Results: Strains carrying fimH-only genotype were significantly more prevalent in lower UTI (P
- Published
- 2022